Company Overview of Enanta Pharmaceuticals, Inc.
Key Executives for Enanta Pharmaceuticals, Inc.
|Jay R. Luly Ph.D.||35 Relationships||Chief Executive Officer, President and Director||60|
|Paul J. Mellett Jr.||No Relationships||Chief Financial Officer and Senior Vice President of Finance & Administration||61|
|Nathalie Adda M.D.||No Relationships||Chief Medical Officer and Senior Vice President||50|
|Nathaniel S. Gardiner J.D.||No Relationships||Senior Vice President, General Counsel and Secretary||62|
|Timothy D. Ocain Ph.D.||10 Relationships||Senior Vice President of New Product Strategy and Development||58|
|View More Key Executives|
Enanta Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Bruce L. A. Carter Ph.D.||200 Relationships||Enanta Pharmaceuticals, Inc.||73|
|Jay R. Luly Ph.D.||35 Relationships||Enanta Pharmaceuticals, Inc.||60|
|Terry C. Vance||26 Relationships||BioMotiv, LLC||58|
|Stephen Buckley Jr.||15 Relationships||Enanta Pharmaceuticals, Inc.||66|
|George S. Golumbeski Ph.D.||23 Relationships||Enanta Pharmaceuticals, Inc.||59|
Enanta Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee Jr.||Stephen Buckley||15 Relationships||2 Executives|
|Compensation Committee Ph.D.||George S. Golumbeski||23 Relationships||3 Executives|
|Nominating Committee||Terry C. Vance||26 Relationships||4 Executives|
|Corporate Governance Committee||Terry C. Vance||26 Relationships||4 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$1.6M|
|Total Value of Options||$542.4K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.